NO20023378D0 - Monohydrat av cis-litium-cyano-4-3-(syklopentyloksy)-4- metoksyfenyl sykloheksankarboksylat - Google Patents

Monohydrat av cis-litium-cyano-4-3-(syklopentyloksy)-4- metoksyfenyl sykloheksankarboksylat

Info

Publication number
NO20023378D0
NO20023378D0 NO20023378A NO20023378A NO20023378D0 NO 20023378 D0 NO20023378 D0 NO 20023378D0 NO 20023378 A NO20023378 A NO 20023378A NO 20023378 A NO20023378 A NO 20023378A NO 20023378 D0 NO20023378 D0 NO 20023378D0
Authority
NO
Norway
Prior art keywords
cyclohexanecarboxylate
cyclopentyloxy
monohydrate
methoxyphenyl
cis
Prior art date
Application number
NO20023378A
Other languages
English (en)
Other versions
NO20023378L (no
Inventor
Kevin Scott Webb
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20023378L publication Critical patent/NO20023378L/no
Publication of NO20023378D0 publication Critical patent/NO20023378D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C255/46—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20023378A 2000-01-26 2002-07-12 Monohydrat av cis-litium-cyano-4-3-(syklopentyloksy)-4- metoksyfenyl sykloheksankarboksylat NO20023378D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17812900P 2000-01-26 2000-01-26
PCT/US2001/001487 WO2001055094A1 (en) 2000-01-26 2001-01-18 Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate

Publications (2)

Publication Number Publication Date
NO20023378L NO20023378L (no) 2002-07-12
NO20023378D0 true NO20023378D0 (no) 2002-07-12

Family

ID=22651319

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023378A NO20023378D0 (no) 2000-01-26 2002-07-12 Monohydrat av cis-litium-cyano-4-3-(syklopentyloksy)-4- metoksyfenyl sykloheksankarboksylat

Country Status (36)

Country Link
US (1) US6699903B2 (no)
EP (1) EP1250313B1 (no)
JP (1) JP2003520842A (no)
KR (1) KR20020073183A (no)
CN (1) CN1157371C (no)
AP (1) AP1432A (no)
AR (1) AR027273A1 (no)
AT (1) ATE344235T1 (no)
AU (1) AU3282201A (no)
BG (1) BG106959A (no)
BR (1) BR0107709A (no)
CA (1) CA2397758A1 (no)
CO (1) CO5300517A1 (no)
CY (1) CY1108515T1 (no)
CZ (1) CZ20022590A3 (no)
DE (1) DE60124221T2 (no)
DK (1) DK1250313T3 (no)
DZ (1) DZ3285A1 (no)
EA (1) EA200200791A1 (no)
EG (1) EG24065A (no)
ES (1) ES2273804T3 (no)
HK (1) HK1051030A1 (no)
HU (1) HUP0204150A3 (no)
IL (1) IL150400A0 (no)
MA (1) MA25652A1 (no)
MX (1) MXPA02007300A (no)
MY (1) MY122802A (no)
NO (1) NO20023378D0 (no)
NZ (1) NZ519799A (no)
OA (1) OA12159A (no)
PE (1) PE20011040A1 (no)
PL (1) PL356832A1 (no)
PT (1) PT1250313E (no)
SK (1) SK10942002A3 (no)
WO (1) WO2001055094A1 (no)
ZA (1) ZA200205925B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011802D0 (en) * 2000-05-16 2000-07-05 Smithkline Beecham Method for enhancing cognitive function

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993019749A1 (en) * 1992-04-02 1993-10-14 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
UA67753C2 (uk) * 1997-10-10 2004-07-15 Смітклайн Бічам Корпорейшн Спосіб отримання заміщених 4-феніл-4-ціанциклогексанових кислот

Also Published As

Publication number Publication date
CN1157371C (zh) 2004-07-14
NZ519799A (en) 2004-04-30
CN1395556A (zh) 2003-02-05
SK10942002A3 (sk) 2002-11-06
PE20011040A1 (es) 2001-10-31
DK1250313T3 (da) 2007-02-12
MA25652A1 (fr) 2002-12-31
DE60124221T2 (de) 2007-09-13
US20030032670A1 (en) 2003-02-13
NO20023378L (no) 2002-07-12
CO5300517A1 (es) 2003-07-31
AR027273A1 (es) 2003-03-19
DZ3285A1 (fr) 2001-08-02
CZ20022590A3 (cs) 2003-01-15
PL356832A1 (en) 2004-07-12
JP2003520842A (ja) 2003-07-08
MY122802A (en) 2006-05-31
EG24065A (en) 2008-05-08
ES2273804T3 (es) 2007-05-16
ATE344235T1 (de) 2006-11-15
US6699903B2 (en) 2004-03-02
DE60124221D1 (de) 2006-12-14
MXPA02007300A (es) 2002-11-29
AP2002002566A0 (en) 2002-06-30
CA2397758A1 (en) 2001-08-02
BG106959A (en) 2003-05-30
EP1250313B1 (en) 2006-11-02
EA200200791A1 (ru) 2002-12-26
EP1250313A4 (en) 2005-09-21
BR0107709A (pt) 2002-11-19
OA12159A (en) 2006-05-08
HUP0204150A3 (en) 2003-05-28
PT1250313E (pt) 2007-01-31
WO2001055094A1 (en) 2001-08-02
AP1432A (en) 2005-06-20
AU3282201A (en) 2001-08-07
KR20020073183A (ko) 2002-09-19
EP1250313A1 (en) 2002-10-23
HUP0204150A2 (hu) 2003-04-28
ZA200205925B (en) 2003-11-21
CY1108515T1 (el) 2014-04-09
IL150400A0 (en) 2002-12-01
HK1051030A1 (zh) 2003-07-18

Similar Documents

Publication Publication Date Title
NO20035087D0 (no) Anvendelse av HMG fragment som anti-inflammatoriske midler
NO20041272L (no) Tetracycline derivatives and methods of use thereof
ID30187A (id) Dongkrak jenis pantagraf
ITMI20011317A1 (it) Porta di aereo
NO20041968L (no) Anvendelse av cystationin
NO20023378D0 (no) Monohydrat av cis-litium-cyano-4-3-(syklopentyloksy)-4- metoksyfenyl sykloheksankarboksylat
EE200300434A (et) Farmatseutiliselt toimivate ühendite kasutamine
NO20013669D0 (no) Reverse hydroksamatinhibitorer av matriks metalloproteinaser
SI1250313T1 (sl) Monohidrat cis-litij-ciano-4(3-(ciklopentiloksi)-4-metoksifenil) cikloheksankarboksilata
DE50214840D1 (de) Ethylestern
ITTO20020756A0 (it) Procedimenti pesticidi e utilizzi di un composto pesticida
UA6113S (uk) Комплект етикеток
UA5715S (uk) Комплект етикеток
UA6496S (uk) Комплект етикеток
UA7541S (uk) Комплект етикеток
UA7542S (uk) Комплект етикеток
UA5149S (uk) Комплект етикеток
UA5777S (uk) Комплект етикеток
UA6137S (uk) Комплект етикеток
UA5027S (uk) Комплект етикеток
UA5988S (uk) Комплект етикеток
UA5714S (uk) Комплект етикеток
UA6257S (uk) Комплект етикеток
UA5775S (uk) Комплект етикеток
UA5776S (uk) Комплект етикеток

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application